Mirtazapine
 
German Version French Version
 

Mirtazapine Mirtazapine, Azamianserin, (RS)-2-Methyl-1,2,3,4,10,14b-hexahydropyranzino[2,1-a]pyrido[2,3-c][2]benzazepine, C17H19N3, M=265.36 g/mol

Tetracyclic Antidepressant

Trade Mark: Remeron®, Mepirepine®

 

Application

Treatment of depressions.

Contraindications

Do not use with alcohol intoxication as well as heavy liver deseases. Do not use during pregnancy.

Interactions

Combination with MAO inhibitors cause fever, cramps and unconsciousness.

Adverse Effects

The vegetative Adverse Effects are somewhat smaller than with the tricyclic antidepressants.

Analytics

The blood level determination of Mirtazapine can take place after extraction by means of HPLC/DAD. Therapeutic blood levels: up to 0,3 µg/ml.

Custom Search

 

 

 

Last modification (M-D-Y): 02/08/2019 - IMPRINT - FAQ